Cargando…

Immunohistochemical Examination of a Resected Advanced Hilar Cholangiocarcinoma Arising in a 29-Year-Old Male without Primary Sclerosing Cholangitis

A 29-year-old man with advanced hilar cholangiocarcinoma was successfully treated with an extended right lobectomy. The carbohydrate antigen 19-9 (CA19-9) level was elevated to 939 IU/l, and the pathological findings revealed moderately differentiated tubular adenocarcinoma which involved almost the...

Descripción completa

Detalles Bibliográficos
Autores principales: Suehiro, Taketoshi, Matsumata, Takashi, Iguchi, Tomohiro, Sanefuji, Kensaku, Nomoto, Ken-ichi, Taketomi, Akinobu, Shirabe, Ken, Maehara, Yoshihiko
Formato: Texto
Lenguaje:English
Publicado: S. Karger AG 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2929407/
https://www.ncbi.nlm.nih.gov/pubmed/20805936
http://dx.doi.org/10.1159/000313791
_version_ 1782185923367141376
author Suehiro, Taketoshi
Matsumata, Takashi
Iguchi, Tomohiro
Sanefuji, Kensaku
Nomoto, Ken-ichi
Taketomi, Akinobu
Shirabe, Ken
Maehara, Yoshihiko
author_facet Suehiro, Taketoshi
Matsumata, Takashi
Iguchi, Tomohiro
Sanefuji, Kensaku
Nomoto, Ken-ichi
Taketomi, Akinobu
Shirabe, Ken
Maehara, Yoshihiko
author_sort Suehiro, Taketoshi
collection PubMed
description A 29-year-old man with advanced hilar cholangiocarcinoma was successfully treated with an extended right lobectomy. The carbohydrate antigen 19-9 (CA19-9) level was elevated to 939 IU/l, and the pathological findings revealed moderately differentiated tubular adenocarcinoma which involved almost the entire thickness of the hepatic duct and the adjacent liver tissue (T3) and which was associated with lymph node metastasis (N1). It was a stage IIB (T3N1M0) tubular adenocarcinoma according to UICC pathological staging. Immunohistochemical examination revealed that Ki-67, cyclin D1, and MMP-7 were positive, and 14-3-3σ and p27 were negative. The pathological and immunohistochemical findings indicated high malignant potential indicating poor prognosis. We administrated the postoperative adjunct gemcitabine combined with S-1 chemotherapy. The patient is alive without recurrence and doing well two years after surgery. We also review other reports of cholangiocarcinoma patients aged less than 30 years.
format Text
id pubmed-2929407
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-29294072010-08-30 Immunohistochemical Examination of a Resected Advanced Hilar Cholangiocarcinoma Arising in a 29-Year-Old Male without Primary Sclerosing Cholangitis Suehiro, Taketoshi Matsumata, Takashi Iguchi, Tomohiro Sanefuji, Kensaku Nomoto, Ken-ichi Taketomi, Akinobu Shirabe, Ken Maehara, Yoshihiko Case Rep Gastroenterol Published: May 2010 A 29-year-old man with advanced hilar cholangiocarcinoma was successfully treated with an extended right lobectomy. The carbohydrate antigen 19-9 (CA19-9) level was elevated to 939 IU/l, and the pathological findings revealed moderately differentiated tubular adenocarcinoma which involved almost the entire thickness of the hepatic duct and the adjacent liver tissue (T3) and which was associated with lymph node metastasis (N1). It was a stage IIB (T3N1M0) tubular adenocarcinoma according to UICC pathological staging. Immunohistochemical examination revealed that Ki-67, cyclin D1, and MMP-7 were positive, and 14-3-3σ and p27 were negative. The pathological and immunohistochemical findings indicated high malignant potential indicating poor prognosis. We administrated the postoperative adjunct gemcitabine combined with S-1 chemotherapy. The patient is alive without recurrence and doing well two years after surgery. We also review other reports of cholangiocarcinoma patients aged less than 30 years. S. Karger AG 2010-05-12 /pmc/articles/PMC2929407/ /pubmed/20805936 http://dx.doi.org/10.1159/000313791 Text en Copyright © 2010 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No-Derivative-Works License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions.
spellingShingle Published: May 2010
Suehiro, Taketoshi
Matsumata, Takashi
Iguchi, Tomohiro
Sanefuji, Kensaku
Nomoto, Ken-ichi
Taketomi, Akinobu
Shirabe, Ken
Maehara, Yoshihiko
Immunohistochemical Examination of a Resected Advanced Hilar Cholangiocarcinoma Arising in a 29-Year-Old Male without Primary Sclerosing Cholangitis
title Immunohistochemical Examination of a Resected Advanced Hilar Cholangiocarcinoma Arising in a 29-Year-Old Male without Primary Sclerosing Cholangitis
title_full Immunohistochemical Examination of a Resected Advanced Hilar Cholangiocarcinoma Arising in a 29-Year-Old Male without Primary Sclerosing Cholangitis
title_fullStr Immunohistochemical Examination of a Resected Advanced Hilar Cholangiocarcinoma Arising in a 29-Year-Old Male without Primary Sclerosing Cholangitis
title_full_unstemmed Immunohistochemical Examination of a Resected Advanced Hilar Cholangiocarcinoma Arising in a 29-Year-Old Male without Primary Sclerosing Cholangitis
title_short Immunohistochemical Examination of a Resected Advanced Hilar Cholangiocarcinoma Arising in a 29-Year-Old Male without Primary Sclerosing Cholangitis
title_sort immunohistochemical examination of a resected advanced hilar cholangiocarcinoma arising in a 29-year-old male without primary sclerosing cholangitis
topic Published: May 2010
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2929407/
https://www.ncbi.nlm.nih.gov/pubmed/20805936
http://dx.doi.org/10.1159/000313791
work_keys_str_mv AT suehirotaketoshi immunohistochemicalexaminationofaresectedadvancedhilarcholangiocarcinomaarisingina29yearoldmalewithoutprimarysclerosingcholangitis
AT matsumatatakashi immunohistochemicalexaminationofaresectedadvancedhilarcholangiocarcinomaarisingina29yearoldmalewithoutprimarysclerosingcholangitis
AT iguchitomohiro immunohistochemicalexaminationofaresectedadvancedhilarcholangiocarcinomaarisingina29yearoldmalewithoutprimarysclerosingcholangitis
AT sanefujikensaku immunohistochemicalexaminationofaresectedadvancedhilarcholangiocarcinomaarisingina29yearoldmalewithoutprimarysclerosingcholangitis
AT nomotokenichi immunohistochemicalexaminationofaresectedadvancedhilarcholangiocarcinomaarisingina29yearoldmalewithoutprimarysclerosingcholangitis
AT taketomiakinobu immunohistochemicalexaminationofaresectedadvancedhilarcholangiocarcinomaarisingina29yearoldmalewithoutprimarysclerosingcholangitis
AT shirabeken immunohistochemicalexaminationofaresectedadvancedhilarcholangiocarcinomaarisingina29yearoldmalewithoutprimarysclerosingcholangitis
AT maeharayoshihiko immunohistochemicalexaminationofaresectedadvancedhilarcholangiocarcinomaarisingina29yearoldmalewithoutprimarysclerosingcholangitis